Global Bone Growth Stimulator Market Size (2024 - 2029)

The bone growth stimulator market is anticipated to experience substantial growth, driven by an increasing prevalence of bone and joint disorders, a rising demand for non-invasive surgical options, and a growing elderly population. The market's expansion is further influenced by the heightened incidence of fractures and trauma cases, particularly among the elderly, which has been exacerbated by the COVID-19 pandemic. Despite initial setbacks due to reduced accidents during lockdowns, the long-term demand for bone growth stimulators is expected to rise as these factors continue to impact the healthcare landscape globally.

Market Size of Global Bone Growth Stimulator Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Bone Growth Stimulator Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 5.90 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Bone Growth Stimulator Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Bone Growth Stimulator Market Analysis

The bone growth stimulator market was valued at approximately USD 985 million in 2020 and is expected to witness a revenue of USD 1,425 million in 2026, with a CAGR of 5.9% over the forecast period.

The impact of COVID-19 on the studied market is expected to be significant. On one hand, due to the lockdown and travel restriction imposed to combat the transmission of the COVID-19 virus, incidences of road accidents and consequent fractures and injuries have reduced, which has highly impacted the studied market. On the other hand, as per a research article published in the Journal of Clinical Pharmacy and Therapeutics, 2020, the elderly population became more prone to bone fractures during the pandemic due to lack of out-of-home activities, sedentary lifestyle, and decreased exposure to sunlight and consequent Vitamin D deficiency. Additionally, as per a research study published in Bone and Joint Open, 2020, there was a significant increase in hip fractures, especially among the elderly population in the United Kingdom, during the pandemic, which was majorly attributed to the lack of caretakers and relatives to take care of the aged people. Thus, the increasing incidence of fractures and trauma cases among the elderly population during the pandemic turns the spotlight on the bone growth stimulators, in turn driving the growth of the studied market.

The bone growth stimulator market is majorly driven by factors such as the rising incidence of bone and joint disorders, growing demand for non-invasive and minimally invasive surgeries across the world, and the growing geriatrics population.

Osteoarthritis is considered to be one of the most prevalent articular diseases among the population above the age of 65 years. According to the Centers for Disease Control and Prevention (CDC), an estimated 63 million Americans have been diagnosed with arthritis, and this number is estimated to reach 78 million by 2040. Additionally, as per World Population Prospects: The 2019 Revision Data, in 2019, 1 in 11 people was above the age of 65 years. This number is expected to increase to 1 in 6 people by 2050.

An increasing incidence of trauma and accident cases worldwide is considered as one of the major factors likely to boost the demand for the studied market. According to the National Safety Council, in 2018, around 4.5 million people were severely injured due to accidents. Thus, given the aforementioned factors, the bone growth stimulator market is expected to witness significant growth over the forecast period globally.

Bone Growth Stimulator Industry Segmentation

A bone growth stimulator is a device that stimulates the natural healing of bones by sending lowlevel pulses of electromagnetic energy to the injury or fusion site. A bone growth stimulator is beneficial after a multi-level fusion procedure or for patients who have certain comorbidities, such as smoking addiction or diabetes. The bone growth stimulator market is segmented by product, application, end user, and geography. By product, the market is segmented into bone growth stimulation devices, bone morphogenetic proteins (BMP), and platelet-rich plasma (PRP). By application, the market is segmented into spinal fusion surgeries, delayed union and non-union bone fractures, oral and maxillofacial surgeries, and other applications. By end user, the market is segmented into hospitals and clinics, home care, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product
Bone Growth Stimulation Devices
External Bone Growth Stimulators
Combined Magnetic Field (CMF) Devices
Capacitive Coupling (CC) Devices
Pulsed Electromagnetic Field (PEMF) Devices
Implanted Bone Growth Stimulators
Ultrasonic Bone Growth Stimulators
Bone Morphogenetic Proteins (BMP)
Platelet-Rich Plasma (PRP)
By Application
Spinal Fusion Surgeries
Delayed Union & Non-union Bone Fractures
Oral and Maxillofacial Surgeries
Other Applications
By End User
Hospitals and Clinics
Home Care
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Bone Growth Stimulator Market Size Summary

The bone growth stimulator market is poised for significant expansion, driven by an increasing prevalence of bone and joint disorders, a growing geriatric population, and a rising demand for non-invasive surgical options. The market's growth trajectory is influenced by the heightened incidence of fractures, particularly among the elderly, exacerbated by lifestyle changes during the COVID-19 pandemic. The pandemic led to a reduction in outdoor activities, contributing to Vitamin D deficiency and increased fracture risk among the elderly. This scenario has underscored the importance of bone growth stimulators, which are becoming increasingly vital in managing bone health and recovery. The market is characterized by a shift towards external bone growth stimulators, which offer advantages such as portability and ease of use, further propelling market growth.

North America dominates the bone growth stimulator market, largely due to its substantial geriatric population and the prevalence of orthopedic conditions. The region's market growth is supported by the presence of major industry players and the approval of advanced medical devices. The COVID-19 pandemic has moderately impacted the market, with a temporary shift in focus towards emergency orthopedic procedures. However, the ongoing demand for effective fracture healing solutions continues to drive market expansion. The market is highly consolidated, with key players like Medtronic, Johnson and Johnson (DePuy Synthes), and Zimmer Biomet leading the charge. These companies are actively pursuing expansion strategies and technological advancements to enhance product availability and meet the growing global demand for bone growth stimulators.

Explore More

Global Bone Growth Stimulator Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Burden of Bone and Joint Disorders

      2. 1.2.2 Growing Demand for the Non-Invasive or Minimally Invasive Surgeries

      3. 1.2.3 Development of Biocompatible Synthetic Bone Grafts

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Surgeries and Limited Medical Reimbursements for Bone Growth Stimulation Products

      2. 1.3.2 Adverse Effects of BMP-Based Treatment

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Product

      1. 2.1.1 Bone Growth Stimulation Devices

        1. 2.1.1.1 External Bone Growth Stimulators

          1. 2.1.1.1.1 Combined Magnetic Field (CMF) Devices

          2. 2.1.1.1.2 Capacitive Coupling (CC) Devices

          3. 2.1.1.1.3 Pulsed Electromagnetic Field (PEMF) Devices

        2. 2.1.1.2 Implanted Bone Growth Stimulators

        3. 2.1.1.3 Ultrasonic Bone Growth Stimulators

      2. 2.1.2 Bone Morphogenetic Proteins (BMP)

      3. 2.1.3 Platelet-Rich Plasma (PRP)

    2. 2.2 By Application

      1. 2.2.1 Spinal Fusion Surgeries

      2. 2.2.2 Delayed Union & Non-union Bone Fractures

      3. 2.2.3 Oral and Maxillofacial Surgeries

      4. 2.2.4 Other Applications

    3. 2.3 By End User

      1. 2.3.1 Hospitals and Clinics

      2. 2.3.2 Home Care

      3. 2.3.3 Other End Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Bone Growth Stimulator Market Size FAQs

The Global Bone Growth Stimulator Market is projected to register a CAGR of 5.90% during the forecast period (2024-2029)

Medtronic Plc, Zimmer Biomet, Orthofix International NV, Johnson and Johnson (DePuy Synthes) and Bioventus LLC are the major companies operating in the Global Bone Growth Stimulator Market.

Bone Growth Stimulator Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)